sialyl
pattern
serum
glycoprotein
agp
nonsymptomat
cat
infect
felin
coronaviru
fcov
possibl
relationship
amount
fcov
shed
faec
investig
blood
three
specif
pathogenfre
cat
group
nonsymptomat
fcovposit
cat
catteri
low
group
b
three
cat
high
group
c
seven
cat
level
faecal
shed
collect
monthli
agp
purifi
serum
western
blot
follow
lectinstain
link
link
sialic
acid
faecal
shed
quantifi
group
c
quantit
polymeras
chain
reaction
variat
agp
sialyl
record
cat
group
c
viral
shed
peak
occurr
felin
infecti
periton
fip
catteri
decreas
month
later
serum
agp
increas
link
sialic
acid
result
suggest
hypersialyl
agp
may
involv
hosteviru
interact
acut
phase
protein
glycoprotein
agp
increas
sever
inflammatori
neoplast
condit
cat
paltrinieri
press
cat
felin
infecti
periton
fip
caus
felin
coronaviru
fcov
increas
agp
particularli
evid
duthi
et
al
paltrinieri
et
al
agp
hyposialyl
ceciliani
et
al
previou
studi
paltrinieri
et
al
demonstr
agp
increas
appear
fip
even
fcovinfect
cat
remain
nonsymptomat
suggest
inflammatori
respons
mount
even
cat
develop
fip
studi
cite
faecal
shed
fcov
quantifi
sequenc
therefor
hamper
abil
assess
whether
increas
serum
agp
level
consequ
higher
viral
load
nonmut
fcov
protect
respons
mutant
strain
howev
month
later
percentag
shedder
decreas
suggest
direct
associ
phenomena
possibl
mediat
alter
sialyl
circul
agp
quantifi
faecal
shed
fcov
degre
agp
sialyl
would
contribut
understand
host
fcov
interact
aim
present
studi
follow
assess
whether
fluctuat
agp
concentr
associ
chang
sialyl
pattern
assess
possibl
relationship
agp
concentr
sialyl
intens
fcov
shed
studi
perform
serum
faecal
sampl
includ
previou
studi
paltrinieri
et
al
store
c
sampl
suffici
volum
remain
proceed
agp
purif
correspond
faecal
sampl
includ
present
studi
cat
group
follow
specif
pathogenfre
spf
cat
six
sera
provid
prof
han
lutz
dr
marina
meli
zurich
univers
three
domest
shorthair
dsh
spf
cat
sampl
twice
interv
whose
serum
agp
level
low
stabl
time
tabl
b
nonsymptomat
fcovinfect
cat
catteri
low
preval
fip
group
correspond
group
previou
studi
record
one
case
fip
past
year
five
cat
dsh
catteri
sampl
monthli
month
faecal
polymeras
chain
reaction
pcr
cat
perform
use
method
employ
former
studi
occasion
posit
serum
antibodi
titr
immunofluoresc
test
low
median
rang
base
data
catteri
classifi
low
preval
fcov
infect
present
studi
sampl
three
cat
sampl
day
avail
serum
agp
concentr
show
signific
differ
time
tabl
c
nonsymptomat
fcovinfect
cat
catteri
high
preval
fip
group
correspond
group
previou
studi
studi
persian
cat
catteri
record
one
four
case
fip
per
year
sampl
monthli
month
percentag
shedder
fcov
antibodi
titr
median
rang
variabl
base
data
catteri
classifi
high
preval
fcov
infect
sampl
seven
cat
includ
present
studi
agp
level
vari
time
high
concentr
seen
sampl
tabl
agp
isol
convent
high
pressur
liquid
chormoatographi
hplc
ion
exchang
chromatographi
purifi
agp
subject
sodium
dodecyl
sulphat
e
polyacrylamid
gel
electrophoresi
sdspage
western
blot
lectinstain
previous
describ
ceciliani
et
al
specif
digoxigeninconjug
lectin
sambucu
nigra
agglutinin
snai
roch
diagnost
penzberg
germani
specif
sialic
acid
link
galactos
maackia
amurensi
agglutinin
maa
roch
specif
sialic
acid
link
galactos
employ
posit
detect
glycan
differenti
kit
roch
use
alkalin
phosphatas
conjug
sheep
antidigoxigenin
immunoglobulin
densitometr
analysi
perform
use
imagemast
softwar
amersham
bioscienc
piscataway
usa
order
rel
quantifi
sialic
acid
part
agp
purifi
spf
cat
pool
use
refer
materi
amount
sialic
acid
express
percentag
intens
compar
refer
materi
arbitrarili
consid
within
group
result
sequenti
timesampl
compar
use
nonparametr
friedman
analysi
varianc
anova
follow
bonferroni
test
lectin
tabl
result
spf
cat
close
distribut
around
valu
pool
serum
group
b
c
show
high
individu
variabl
variabl
togeth
low
number
anim
examin
like
respons
lack
signific
differ
spite
evid
variat
mean
valu
among
sequenti
sampl
nevertheless
group
c
sialic
acid
link
galactos
tend
decreas
sampl
significantli
increas
sampl
differ
group
c
group
breed
composit
level
fcov
contamin
breedrel
differ
agp
sialyl
unlik
base
result
test
perform
cat
differ
breed
data
includ
studi
differ
record
thu
like
depend
fcov
infect
interestingli
previou
studi
antibodi
titr
concentr
agp
increas
sampl
week
occurr
episod
fip
catteri
increas
sialyl
record
could
thu
interpret
protect
respons
viru
possibl
mediat
interact
fcov
sialyl
agp
moreov
hypersialyl
elong
halflif
circul
protein
gregoriadi
et
al
may
partli
explain
concentr
serum
agp
show
sampl
increas
record
sampl
sampl
follow
outbreak
fip
human
agp
immunomodulatori
function
vasson
et
al
degre
glycosyl
influenc
suscept
resist
virus
rabehi
et
al
speci
coronaviru
high
affin
sialyl
molecul
schwegmannwessel
herrler
although
affin
fcov
sialic
acid
yet
investig
result
present
stimul
futur
research
topic
spearmann
correl
test
show
level
sialyl
posit
tabl
data
regard
serum
agp
concentr
mgml
antibodi
titr
record
differ
sampl
cat
includ
studi
paltrinieri
et
al
percentag
sialyl
record
individu
sera
stain
lectin
snai
maa
statist
correl
serum
concentr
agp
suggest
agp
product
sialyl
driven
independ
mechan
regard
faecal
shed
group
c
cdna
synthesis
former
studi
store
c
use
current
studi
quantit
pcr
perform
previous
describ
battilani
et
al
corbett
research
rotorgen
real
time
amplif
system
corbett
research
mortlak
nsw
australia
use
quantitect
sybr
green
pcr
kit
qiagen
hilden
germani
forward
revers
primer
gut
et
al
number
copi
rna
sampl
compar
use
nonparametr
test
mention
sampl
former
studi
neg
tradit
pcr
copi
rna
among
sampl
posit
tradit
pcr
four
neg
seven
less
copi
rna
copi
rna
rare
except
median
rna
excret
moder
sampl
copi
rna
significantli
increas
p
sampl
significantli
decreas
sampl
three
zero
fig
signific
correl
agp
concentr
sialyl
faecal
shed
found
like
due
extrem
variabl
data
faec
despit
lack
signific
correl
differ
paramet
show
common
trend
sampl
amount
shed
increas
follow
decreas
sampl
antibodi
titr
serum
agp
concentr
increas
two
week
later
two
episod
fip
occur
catteri
sampl
antibodi
titr
return
normal
level
percentag
shedder
decreas
simultan
serum
concentr
agp
decreas
increas
sialyl
one
month
later
percentag
shedder
antibodi
titr
increas
agp
hypersialyl
spite
normal
serum
level
find
support
hypothesi
hypersialyl
agp
may
one
factor
could
explain
fcovinfect
cat
develop
fip
spite
presenc
larg
amount
viral
rna
shed
environ
conclus
sialyl
serum
agp
fluctuat
clinic
healthi
cat
catteri
high
preval
fcov
infect
fluctuat
statist
correl
amount
agp
fcov
statu
cat
notic
occurr
fip
catteri
associ
decreas
viral
shed
support
hypothesi
hypersialyl
agp
might
interact
fcov
possibl
confer
protect
develop
fip
stimul
research
possibl
role
agp
confer
resistancesuscept
fcov
infect
